Mass spectrometry of peptides: can it prove identity? The principle of LC-MS/MS and why matching mass isn’t always enough?

A vial of a synthetic research peptide arrives at a lab. Someone dissolves a little of the powder, puts it on the mass spectrometer and waits for a number. That number matches the mass the peptide should have, almost to the decimal point. So the vial holds the right peptide, doesn’t it?Usually, yes, but a matching mass can’t prove it on its own. To be fair, few tools beat peptide mass spectrometry for checking a synthetic peptide, and a matching mass counts for a lot. But mass only tells you what went into a molecule. It doesn’t always tell you in what order. Shuffle the same amino acids and you have a new peptide that weighs precisely what the old one did.Below, we walk through LC-MS peptide testing step by step, look at why the right mass isn’t always the end of the story and see what tandem mass spectrometry (MS/MS) can add. We’ll also look at how far a single result really gets a research lab.

What does mass spectrometry actually tell us about a peptide?

In plain terms, MS testing (mass spectrometry testing) tells you how heavy the molecules in a sample are. Think of the instrument as a scale, just a very picky one that works a little differently from the one in your kitchen. Neutral molecules are no use to it. It gives them a charge first, which turns them into ions, and then separates or detects them according to their mass-to-charge ratio (m/z).Synthetic research peptides make the job easier, because the lab knows the answer it’s hoping to see. Nobody has to guess the sequence, because it was chosen before synthesis even started. The masses of the amino acids aren’t a mystery either – they’re printed in every chemistry handbook. Add them together, take off the water released each time two amino acids join, and that’s the number the lab is looking for.So the test is really a comparison. When the measured figure lands where it should, within what the instrument can reliably tell apart, that’s a good sign the right molecule is in the vial. Prabhala and colleagues make the same point in their 2024 chapter on characterizing synthetic peptides by mass spectrometry, published in the Methods in Molecular Biology series. Since the sequence is usually known, they note, the analysis is mainly there to confirm identity rather than to puzzle out an unknown structure.A match is good evidence, but it isn’t proof. It rules out a lot of possible problems, such as a missing amino acid or an unexpected chemical change. What it can’t rule out is a different structure that happens to be built from exactly the same atoms.It also helps to keep two questions apart. Identity asks: is this the right molecule? Purity asks: how much of the sample is that molecule, and how much is something else? Purity is often assessed using hplc purity analysis with UV detection, while mass spectrometry is the main tool for identity. Labs working with research peptides often run both, because each answers a different question and neither can stand in for the other.

How LC-MS peptide testing works – from sample to spectrum?

What is LC-MS testing? In short, it’s a two-part lab test. Liquid chromatography (LC) first separates a sample into its components, and a mass spectrometer (MS) then measures each component as it comes out. In LC-MS analysis of peptides, the main question is whether the main component has the molecular mass its sequence predicts. Plain MS testing skips the separation step and measures everything in the sample at once.That’s LC-MS explained in brief. It’s the standard setup for peptide analysis by mass spectrometry, and the principle of LC-MS makes most sense if you follow a single sample through it.Sample preparation. First, a little of the research peptide goes into solution, typically water with some acetonitrile mixed in. It’s then diluted, because the instrument works best within a certain concentration range.Liquid chromatography. The solution is pushed through a thin column packed with very fine particles. Molecules cling to those particles to different degrees. The ones that cling least come out first, and the stickier ones come out later. You might think of this as tidying up before the real measurement, but the separation decides a lot of what the mass spectrometer can see. A peptide and a near-twin impurity that hit the detector together are far harder to sort out than two that turn up a minute apart.Ionization. Next problem: the mass spectrometer only works with charged molecules in the gas phase, and right now the peptide is dissolved in a liquid. For peptides, the go-to fix is electrospray ionization, or ESI. The liquid is sprayed through a fine needle at high voltage. The spray forms a mist of charged droplets. They shrink as the solvent evaporates, and eventually the peptide molecules break free, each carrying a few extra protons. The big advantage of ESI is that it doesn’t smash large, fragile molecules apart.Mass analysis. Here is a detail many explanations skip. Strictly speaking, the instrument never measures mass. What it reads is mass divided by charge, or m/z. A peptide carrying two extra protons shows up at about half its mass. One carrying three shows up at about a third.That’s why a single peptide often gives several signals in a peptide LC-MS run. Take exenatide, a 39-amino-acid synthetic peptide. Its monoisotopic mass is about 4184.03 Da, yet you usually won’t see a signal anywhere near 4184 in its spectrum. Carrying three protons, it appears around m/z 1395.7, and carrying four, around m/z 1047.0.Results. Software looks at how these signals are spaced and works back to one mass for the uncharged molecule. This step is called deconvolution. That number is then compared with the mass calculated from the sequence.You’ll see several related abbreviations on analytical reports for research peptides, and each one tells you how much of this process was used. MS means mass measurement on its own, with no separation beforehand. LC-MS is the full route described above: separation first, then mass measurement. MS/MS, or tandem mass spectrometry, goes one step further. It picks out selected ions, breaks them into fragments and measures the fragments too. LC-MS/MS combines the separation with both stages of measurement in a single run.

Same mass, different peptide – the hidden problem of molecular identity

Think of an anagram. “Listen” and “silent” use exactly the same letters, so they would weigh the same on a scale if you cut them out of paper. They are still different words. Peptides can work the same way.The simplest real example uses two amino acids, glycine (Gly) and alanine (Ala). Join them one way and you get Gly-Ala. Join them the other way and you get Ala-Gly. Both have the formula C5H10N2O3 and the same monoisotopic mass, 146.069 Da. They are two different compounds, yet an instrument measuring the whole molecule can’t tell them apart. A more accurate instrument wouldn’t help, because there is no difference in mass to find.Longer peptides have the same issue. Any peptide can be rearranged into other sequences that use the same amino acids, and every one of them has exactly the same mass. To be clear, this isn’t the most common problem when research peptides are synthesized. The usual leftovers are chains with a missing or chemically changed amino acid, and those do change the mass. The point is simply that if a rearranged sequence were present, the mass alone wouldn’t show it.Leucine and isoleucine are a trickier case. They are two different amino acids with the same formula, C6H13NO2. The only difference is how their side chains branch. Put leucine or isoleucine at the same spot in a peptide and the mass is identical. Even standard fragmentation tests often can’t tell them apart. It can be done, but it usually takes special techniques, such as the multistep method Xiao and colleagues described in 2016. Other look-alikes that need special methods include the mirror-image D- and L-forms of an amino acid and isoaspartic acid, a rearranged form of aspartic acid, as Jansson’s review explains.Very precise instruments do help with near misses, meaning peptides whose masses are close but not quite the same. He and colleagues showed that high-end instruments can separate many of these pairs, including one where the masses differed by just 11 thousandths of a dalton. But when the masses are truly identical, extra precision can’t help.Two ideas are worth keeping apart here:Measurement accuracy is how close the measured mass is to the true mass.Identification confidence is how strongly all the evidence points to one specific structure and not another.A result can be excellent on the first and still leave the second open, if more than one structure fits the same number. That isn’t a fault in mass spectrometry. It’s simply what a mass measurement can and can’t tell you.

How MS/MS provides more evidence about peptide structure?

If the mass of the whole molecule isn’t enough, the next step is to break it apart and look at the pieces. That is what tandem mass spectrometry does.Stage one is a filter. Out of everything flying through the instrument, it keeps only the ions with one chosen m/z value – ideally the intact peptide, known as the precursor ion. Those ions then get knocked about, usually by sending them into a cloud of gas such as nitrogen or argon, until they fall apart. Stage two weighs the bits. Put a chromatography column in front of all this and you’ve got the principle of LC-MS/MS in a nutshell: separate the sample, measure the whole ion, then break it up and measure the pieces.Peptides tend to break in the same places, most often at the bonds that link one amino acid to the next. Each break leaves two kinds of fragment. A b ion holds the beginning of the chain, called the N-terminus. A y ion holds the end, called the C-terminus. Fragments next to each other in a series differ by exactly one amino acid, so the gaps between their masses can be read almost like letters in a word. That’s the basic idea behind MS/MS peptide identification, and the b and y naming system has been in use since the 1980s.Back to Gly-Ala and Ala-Gly. The whole molecules weigh the same, but their y1 fragments don’t. The y1 fragment is the last amino acid in the chain, carrying a proton. For Gly-Ala, that’s alanine, at m/z 90.055. For Ala-Gly, it’s glycine, at m/z 76.039. Detecting the corresponding y1 fragment can help distinguish these two sequences, provided the fragment is reliably identified.The same idea works on real-sized peptides. In a study by Agilent, researchers looked at bivalirudin, a synthetic peptide 20 amino acids long. LC/MS found a component 129 Da lighter than the target, which matched a missing glutamic acid. Specific b and y fragments from LC/MS/MS then showed where in the chain it was missing.Peptide fragmentation mass spectrometry has limits too, and they’re worth spelling out:A peptide hardly ever breaks at every single bond, which can leave gaps in the sequence.Standard collision-based MS/MS still can’t tell leucine from isoleucine, because their fragments weigh the same.Reading the results takes care. Each signal has to be matched to the right fragment, and some spectra simply don’t contain enough information.Results vary with the instrument, how it’s set up and the research peptide being tested. Size, charge and chemistry all play a part.MS/MS, in other words, says a great deal about the sequence. It just doesn’t come with a guarantee for every amino acid.

What else can peptide mass spectrometry reveal?

Plenty of things that can go wrong with a research peptide, during synthesis or in storage, also change its weight. That makes LC-MS peptide analysis handy for catching the target’s close relatives.Missing or extra amino acids. If an amino acid is missing, the mass drops by that amino acid’s weight, about 57 Da for glycine or 129 Da for glutamic acid. An extra one adds the same amount.Chemical changes. Oxidation, most often of methionine, adds about 16 Da, the weight of one oxygen atom. Deamidation, where asparagine or glutamine turns into aspartic or glutamic acid, adds just under 1 Da. A shift that small needs a high-resolution instrument, because it sits very close to the peptide’s own natural isotope signals.Other components. In the bivalirudin study, an aged sample showed five main peaks: the full peptide, a version missing glycine, a version missing glutamic acid, a version that had lost a water molecule, and a deamidated version. In a Waters study, exenatide was kept at 37 °C for several days, and the analysis found oxidized, double-oxidized and paired-up (dimer) forms, among others. If you want to know where by-products like these come from in research peptides, see our article on peptide impurities.What a test can find always depends on the method. Detection depends on ionization efficiency, signal intensity, interference from other components, instrument sensitivity and, in some cases, chromatographic separation. A clean result means nothing was detected under those conditions. It doesn’t mean nothing is there.

What mass spectrometry cannot prove about a peptide?

Mass spectrometry of peptides is very good at some questions and can’t answer others at all, so it’s worth knowing which is which.A peptide mass spec result can show whether something with the expected mass is present, usually very accurately. The mass of the whole molecule can’t prove the amino acid sequence on its own, because rearranged sequences weigh the same. MS/MS closes much of that gap, but it can still leave some positions, or look-alike amino acids, unconfirmed.LC-MS can pick up many impurities, but not every possible one. Some come out of the column at the same time as the main peptide, some don’t take on a charge easily, and some are present in amounts too small to detect.Knowing how to test peptides for purity is a separate question from establishing identity. How much peptide a research sample actually contains is another question again. The size of a signal depends not only on how much of a substance is there, but also on how easily it picks up a charge, and that varies from one molecule to another and from one set of conditions to another. Two signals of the same size don’t necessarily mean equal amounts. To measure how much peptide a sample really contains, a lab needs a proper quantitative method, with calibration and reference standards.Some things are simply beyond the method. Mass spectrometry can’t tell you whether a sample is sterile, and it isn’t a test for endotoxins in peptides. Those need their own dedicated tests.All of this matters when you see a line in a research peptide report such as “Identity confirmed” or “MS: Pass”. That line only means as much as the test behind it: which technique was used, what mass was expected, how big a difference still counted as a match, and whether fragment data were included. Those details are what make a result on a peptide certificate of analysis meaningful.

How much evidence is enough to identify a research peptide?

For a broader look at how to tell if peptides are real, identity testing is only one part of the evidence. No single number settles whether a peptide is what it should be. It’s more useful to think of the evidence in layers. The three levels below are just a way to picture it, not an official lab classification.Level 1 – expected mass detected. The measured mass matches the mass calculated from the sequence. That’s an important result and rules out a lot of errors, but it doesn’t always rule out other structures with the same mass.Level 2 – additional structural evidence. MS/MS fragments, or other suitable methods, add information about the sequence and structure. This is where a question like Gly–Ala versus Ala–Gly gets answered.Level 3 – results evaluated together. All the findings are looked at side by side, along with the method used, what the sample is like, the pass criteria and the results of other tests, such as purity by chromatography.For many synthetic research peptides, a matching high-resolution mass and a clean chromatographic profile provide strong supporting evidence of identity. However, they do not necessarily confirm the amino acid sequence or distinguish structural isomers. When the question is harder, for example a sequence with look-alike amino acids or a suspected impurity with the same mass as the target, MS/MS and sometimes other techniques provide what the mass alone can’t. It’s also why a batch-specific COA tells you more than a generic one: the evidence is about the material that’s actually in the vial.

The right mass is evidence, not the whole answer

Mass spectrometry is one of the most powerful tools for checking synthetic research peptides. When the measured mass matches the expected one, many possible errors are ruled out, and that’s a central part of confirming identity. What the mass can’t always do on its own is tell apart molecules that weigh exactly the same. Tandem MS adds information about the sequence by breaking the molecule into pieces, though it has limits of its own. Confident peptide identification by mass spectrometry comes from choosing the right tests for the question and reading their results with those limits in mind.ReferencesPrabhala BK, Mirza OA, Højrup P, Hansen PR. Characterization of synthetic peptides by mass spectrometry. Methods in Molecular Biology. 2024.Interpretation of tandem mass spectrometry (MS-MS) spectra for peptide analysis. Methods in Molecular Biology. 2024.Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64–71.He F, Emmett MR, Håkansson K, Hendrickson CL, Marshall AG. Theoretical and experimental prospects for protein identification based solely on accurate mass measurement. Journal of Proteome Research. 2004;3(1):61–67.Jansson ET. Strategies for analysis of isomeric peptides. Journal of Separation Science. 2018;41(1):385–397.Xiao Y, Vecchi MM, Wen D. Distinguishing between leucine and isoleucine by integrated LC–MS analysis using an Orbitrap Fusion mass spectrometer. Analytical Chemistry. 2016;88(21):10757–10766.Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry. 1984;11(11):601.Coffey A, Qin V. Analysis of a synthetic peptide and its impurities. Agilent Technologies application note 5994-2760EN. 2020.Ranbaduge N, Shion H, Yu YQ. Streamlined LC-MS analysis of stress induced impurities of a synthetic peptide using the BioAccord system and the waters_connect Intact Mass application. Waters application note 720007752. 2022.Nobel Prize Outreach. The Nobel Prize in Chemistry 2002.